Insight Molecular Diagnostics EBITDA Margin 2014-2025 | IMDX
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Insight Molecular Diagnostics (IMDX) over the last 10 years. The current EBITDA margin for Insight Molecular Diagnostics as of June 30, 2025 is .
| Insight Molecular Diagnostics EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-06-30 | $0.00B | $-0.06B | -1525.00% |
| 2025-03-31 | $0.00B | $-0.06B | -1866.67% |
| 2024-12-31 | $0.00B | $-0.06B | -5900.00% |
| 2024-09-30 | $0.00B | $-0.04B | 0.00% |
| 2024-06-30 | $0.00B | $-0.04B | 0.00% |
| 2024-03-31 | $0.00B | $-0.04B | 0.00% |
| 2023-12-31 | $0.00B | $-0.02B | 0.00% |
| 2023-09-30 | $0.00B | 0 | 0.00% |
| 2023-06-30 | $0.00B | $0.01B | 0.00% |
| 2023-03-31 | $0.00B | $0.01B | 0.00% |
| 2022-12-31 | $0.00B | $0.01B | 0.00% |
| 2022-09-30 | $0.00B | $-0.02B | 800.00% |
| 2022-06-30 | $0.00B | $-0.03B | 2800.00% |
| 2022-03-31 | $0.00B | $-0.04B | -4000.00% |
| 2021-12-31 | $0.00B | $-0.05B | -2450.00% |
| 2021-09-30 | $0.01B | $-0.04B | -840.00% |
| 2021-06-30 | $0.01B | $-0.04B | -700.00% |
| 2021-03-31 | $0.00B | $-0.03B | -1066.67% |
| 2020-12-31 | $0.00B | $-0.03B | -1450.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.071B | $0.002B |
| Insight Molecular Diagnostics Inc. is a pioneering diagnostics technology company. Insight Molecular Diagnostics Inc., formerly known as Oncocyte Corporation, is based in NASHVILLE, Tenn. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.128B | 58.69 |
| Tempus AI (TEM) | United States | $13.327B | 0.00 |
| Doximity (DOCS) | United States | $12.012B | 53.44 |
| Hims & Hers Health (HIMS) | United States | $9.936B | 81.41 |
| IRhythm Technologies (IRTC) | United States | $5.355B | 0.00 |
| Hinge Health (HNGE) | United States | $4.369B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.710B | 39.83 |
| Privia Health (PRVA) | United States | $2.618B | 193.91 |
| Heartflow (HTFL) | $2.348B | 0.00 | |
| Phreesia (PHR) | United States | $1.711B | 0.00 |
| Enovis (ENOV) | United States | $1.686B | 8.91 |
| 10x Genomics (TXG) | United States | $1.631B | 0.00 |
| Omnicell (OMCL) | United States | $1.465B | 28.22 |
| Schrodinger (SDGR) | United States | $1.441B | 0.00 |
| Azenta (AZTA) | United States | $1.368B | 59.68 |
| Clover Health Investments (CLOV) | United States | $1.338B | 0.00 |
| Claritev (CTEV) | United States | $1.131B | 0.00 |
| Evolent Health (EVH) | United States | $1.030B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.655B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.580B | 0.00 |
| Veradigm (MDRX) | United States | $0.525B | 0.00 |
| Standard BioTools (LAB) | United States | $0.458B | 0.00 |
| Talkspace (TALK) | United States | $0.456B | 136.00 |
| Butterfly Network (BFLY) | United States | $0.350B | 0.00 |
| Carlsmed (CARL) | United States | $0.342B | 0.00 |
| TruBridge (TBRG) | United States | $0.296B | 51.87 |
| Outset Medical (OM) | United States | $0.243B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.232B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.216B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.215B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.190B | 0.00 |
| CapsoVision (CV) | United States | $0.186B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.145B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.121B | 0.00 |
| CareCloud (CCLD) | United States | $0.115B | 5.23 |
| American Well (AMWL) | United States | $0.113B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.090B | 0.00 |
| Pulmonx (LUNG) | United States | $0.062B | 0.00 |
| 111 (YI) | China | $0.062B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.053B | 0.00 |
| HeartBeam (BEAT) | United States | $0.037B | 0.00 |
| Precipio (PRPO) | United States | $0.023B | 0.00 |
| Zhongchao (ZCMD) | China | $0.023B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.016B | 0.00 |
| PROFUSA (PFSA) | United States | $0.015B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.012B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |